Orgenesis Inc. (ORGS)
Company Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide.
The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network.
It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient.
The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011.
Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Country | United States |
Founded | 2008 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 167 |
CEO | Ms. Vered Caplan M.Sc. |
Contact Details
Address: 20271 Goldenrod Lane Germantown, Maryland 20876 United States | |
Phone | (480) 659-6404 |
Website | orgenesis.com |
Stock Details
Ticker Symbol | ORGS |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001460602 |
CUSIP Number | 68619K204 |
ISIN Number | US68619K2042 |
Employer ID | 98-0583166 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Vered Caplan M.Sc. | Chairperson of the Board, Chief Executive Officer and President |
Prof. Sarah Ferber Ph.D. | Founder and Chief Scientific Officer |
Victor Miller | Chief Financial Officer |
Pierre Lammeretz | Interim Chief Operating Officer |
Dr. Shimon Hassin Ph.D. | Chief Technology Officer |
Evan Fishman | Chief Financial Officer of Orgenesis Biotech |
Joseph Carpinelli | Chief Financial Officer of Octomera |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2024 | 8-K | Current Report |
Mar 14, 2024 | D | Notice of Exempt Offering of Securities |
Mar 7, 2024 | 8-K | Current Report |
Mar 1, 2024 | 8-K | Current Report |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 31, 2024 | 8-K | Current Report |
Jan 24, 2024 | 8-K | Current Report |
Jan 22, 2024 | 8-K | Current Report |
Jan 5, 2024 | 8-K | Current Report |
Dec 29, 2023 | 8-K | Current Report |